Try our Advanced Search for more refined results
October 11, 2018
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
Case Number:
1:18-cv-01562
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 18, 2019
AstraZeneca's IP Suit Sent To W.Va. On TC Heartland Grounds
A Delaware federal judge on Friday transferred AstraZeneca AB's suit accusing Mylan Pharmaceuticals Inc. of infringing patents for its asthma treatment Symbicort to West Virginia court, invoking the U.S. Supreme Court's 2017 TC Heartland decision.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login